Identification of high-risk subgroups in very elderly intensive care unit patients.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMC 2206449)

Published in Crit Care on January 01, 2007

Authors

Sophia E de Rooij1, Ameen Abu-Hanna, Marcel Levi, Evert de Jonge

Author Affiliations

1: Department of Geriatrics, Academic Medical Center, University of Amsterdam, Meibergdreef 9 1105 AZ, Amsterdam, The Netherlands. s.e.derooij@amc.nl

Articles cited by this

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics (1988) 70.41

APACHE II: a severity of disease classification system. Crit Care Med (1985) 69.83

The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest (1991) 16.06

Understanding the treatment preferences of seriously ill patients. N Engl J Med (2002) 10.84

Use of intensive care at the end of life in the United States: an epidemiologic study. Crit Care Med (2004) 9.06

The influence of the probability of survival on patients' preferences regarding cardiopulmonary resuscitation. N Engl J Med (1994) 6.39

A simplified acute physiology score for ICU patients. Crit Care Med (1984) 4.55

Decision-making in the ICU: perspectives of the substitute decision-maker. Intensive Care Med (2002) 2.09

Quality of data collected for severity of illness scores in the Dutch National Intensive Care Evaluation (NICE) registry. Intensive Care Med (2002) 1.63

A method for predicting survival and mortality of ICU patients using objectively derived weights. Crit Care Med (1985) 1.52

Decision-making and outcomes of prolonged ICU stays in seriously ill patients. J Am Geriatr Soc (2000) 1.41

Factors that predict outcome of intensive care treatment in very elderly patients: a review. Crit Care (2005) 1.37

Decisions to forgo life-sustaining therapy in ICU patients independently predict hospital death. Intensive Care Med (2003) 1.25

Factors affecting the performance of the models in the Mortality Probability Model II system and strategies of customization: a simulation study. Crit Care Med (1996) 1.21

[Intensive care medicine in the Netherlands, 1997-2001. I. Patient population and treatment outcome]. Ned Tijdschr Geneeskd (2003) 1.19

Determining resuscitation preferences of elderly inpatients: a review of the literature. CMAJ (2003) 0.99

Outcome of older patients receiving mechanical ventilation. Intensive Care Med (2004) 0.97

Modal preferences predict elderly patients' life-sustaining treatment choices as well as patients' chosen surrogates do. Med Decis Making (2000) 0.94

Economic evaluation of new therapies in critical illness. Crit Care Med (2003) 0.92

Outcome of older patients with severe pneumonia predicted by recursive partitioning. J Am Geriatr Soc (2001) 0.85

What defines intermediate-risk prostate cancer? Variability in published prognostic models. Int J Radiat Oncol Biol Phys (2004) 0.84

The limits of proxy decision making: overtreatment. Camb Q Healthc Ethics (1995) 0.82

Risk prediction after myocardial infarction. Comparison of three multivariate methodologies. Cardiology (1983) 0.79

Articles by these authors

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation (2011) 6.47

Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet (2011) 4.78

Prevention and treatment of major blood loss. N Engl J Med (2007) 4.72

Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med (2004) 3.89

Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma (2008) 3.40

Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med (2006) 3.13

Association Between Arterial Hyperoxia and Outcome in Subsets of Critical Illness: A Systematic Review, Meta-Analysis, and Meta-Regression of Cohort Studies. Crit Care Med (2015) 2.96

Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet (2003) 2.86

2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol (2010) 2.75

Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med (2006) 2.75

Evaluation of SOFA-based models for predicting mortality in the ICU: A systematic review. Crit Care (2008) 2.74

The optimal intensity of vitamin K antagonists in patients with mechanical heart valves: a meta-analysis. J Am Coll Cardiol (2003) 2.71

A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit Care Med (2013) 2.68

Temporal abstraction for feature extraction: a comparative case study in prediction from intensive care monitoring data. Artif Intell Med (2007) 2.66

The impact of computerized physician medication order entry in hospitalized patients--a systematic review. Int J Med Inform (2007) 2.59

Dose-finding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors. J Clin Oncol (2002) 2.55

Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ Res (2005) 2.46

Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol (2007) 2.46

Evaluation of outpatient computerized physician medication order entry systems: a systematic review. J Am Med Inform Assoc (2007) 2.20

Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents alveolar coagulation in patients without lung injury. Anesthesiology (2006) 2.19

Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk. Blood (2010) 2.14

A comparison of the performance of a model based on administrative data and a model based on clinical data: effect of severity of illness on standardized mortality ratios of intensive care units. Crit Care Med (2012) 2.13

Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med (2005) 2.12

Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood (2008) 2.03

Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes (2006) 1.97

Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension. Hypertension (2008) 1.95

Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1. Circ Res (2006) 1.95

Management of adult Jehovah's Witness patients with acute bleeding. Am J Med (2009) 1.89

Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. Blood (2007) 1.86

Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia. Crit Care Med (2006) 1.82

A comparison of RIFLE with and without urine output criteria for acute kidney injury in critically ill patients. Crit Care (2012) 1.78

Clinicians' response to hyperoxia in ventilated patients in a Dutch ICU depends on the level of FiO2. Intensive Care Med (2010) 1.77

Cardiac output response to norepinephrine in postoperative cardiac surgery patients: interpretation with venous return and cardiac function curves. Crit Care Med (2013) 1.73

Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a "two-hit" in vivo syngeneic transfusion model. Anesthesiology (2010) 1.72

New fundamentals in hemostasis. Physiol Rev (2013) 1.70

Auditing description-logic-based medical terminological systems by detecting equivalent concept definitions. Int J Med Inform (2007) 1.67

Struggle for implementation of new strategies in intensive care medicine: anticoagulation, insulin, and lower tidal volumes. J Crit Care (2005) 1.66

Effect of changes over time in the performance of a customized SAPS-II model on the quality of care assessment. Intensive Care Med (2011) 1.65

Quality of data collected for severity of illness scores in the Dutch National Intensive Care Evaluation (NICE) registry. Intensive Care Med (2002) 1.63

The impact of different prognostic models and their customization on institutional comparison of intensive care units. Crit Care Med (2007) 1.62

Serum levels of mannose-binding lectin and the risk of future coronary artery disease in apparently healthy men and women. Arterioscler Thromb Vasc Biol (2006) 1.62

Prediction of long-term mortality in ICU patients: model validation and assessing the effect of using in-hospital versus long-term mortality on benchmarking. Intensive Care Med (2013) 1.61

Time course of platelet counts in critically ill patients. Crit Care Med (2002) 1.60

Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology. J Clin Microbiol (2005) 1.60

Mortality after hospital discharge in ICU patients. Crit Care Med (2013) 1.60

The coming of age of artificial intelligence in medicine. Artif Intell Med (2008) 1.60

Antithrombin inhibits bronchoalveolar activation of coagulation and limits lung injury during Streptococcus pneumoniae pneumonia in rats. Crit Care Med (2008) 1.58

Transfusion of fresh-frozen plasma in critically ill patients with a coagulopathy before invasive procedures: a randomized clinical trial (CME). Transfusion (2014) 1.58

Effect of a multifaceted performance feedback strategy on length of stay compared with benchmark reports alone: a cluster randomized trial in intensive care*. Crit Care Med (2013) 1.56

Activation of coagulation and inhibition of fibrinolysis in the human lung on bronchial instillation of lipoteichoic acid and lipopolysaccharide. Crit Care Med (2009) 1.55

Bayesian networks in biomedicine and health-care. Artif Intell Med (2004) 1.54

Pulmonary activation of coagulation and inhibition of fibrinolysis after burn injuries and inhalation trauma. J Trauma (2011) 1.54

Determinants of mortality after hospital discharge in ICU patients: literature review and Dutch cohort study. Crit Care Med (2013) 1.54

Outcomes Associated With the Nationwide Introduction of Rapid Response Systems in The Netherlands. Crit Care Med (2015) 1.53

Effectiveness and Clinical Outcomes of a Two-Step Implementation of Conservative Oxygenation Targets in Critically Ill Patients: A Before and After Trial. Crit Care Med (2016) 1.47

Salivating for knowledge: potential pharmacological agents in tick saliva. PLoS Med (2008) 1.46

Time-course of cytokines during delirium in elderly patients with hip fractures. J Am Geriatr Soc (2008) 1.45

A systematic review on quality indicators for tight glycaemic control in critically ill patients: need for an unambiguous indicator reference subset. Crit Care (2008) 1.44

Dobutamine does not influence inflammatory pathways during human endotoxemia. Crit Care Med (2006) 1.44

Questionnaires on Family Satisfaction in the Adult ICU: A Systematic Review Including Psychometric Properties. Crit Care Med (2015) 1.43

How nurses and physicians judge their own quality of care for deteriorating patients on medical wards: self-assessment of quality of care is suboptimal*. Crit Care Med (2012) 1.43

The influence of volume and intensive care unit organization on hospital mortality in patients admitted with severe sepsis: a retrospective multicentre cohort study. Crit Care (2007) 1.43

Influence of entry criteria on mortality risk and number of eligible patients in recent studies on severe sepsis. Crit Care Med (2005) 1.43

Cytokines and acute phase response in delirium. J Psychosom Res (2007) 1.42

Glucose variability measures and their effect on mortality: a systematic review. Intensive Care Med (2011) 1.42

Endogenous tissue-type plasminogen activator impairs host defense during severe experimental Gram-negative sepsis (melioidosis)*. Crit Care Med (2012) 1.41

Emergence of multidrug-resistant Gram-negative bacteria during selective decontamination of the digestive tract on an intensive care unit. J Antimicrob Chemother (2006) 1.40

Postoperative pro-adrenomedullin levels predict mortality in thoracic surgery patients: comparison with Acute Physiology and Chronic Health Evaluation IV Score*. Crit Care Med (2015) 1.39

Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia. J Immunol (2002) 1.39

Performance of risk-adjusted control charts to monitor in-hospital mortality of intensive care unit patients: a simulation study. Crit Care Med (2012) 1.39

Geriatric conditions in acutely hospitalized older patients: prevalence and one-year survival and functional decline. PLoS One (2011) 1.39

Inappropriateness of medication prescriptions to elderly patients in the primary care setting: a systematic review. PLoS One (2012) 1.38

Individual and Clustered Rankability of ICUs According to Case-Mix-Adjusted Mortality. Crit Care Med (2016) 1.38

Factors that predict outcome of intensive care treatment in very elderly patients: a review. Crit Care (2005) 1.37

Tissue factor and coronary artery disease. Cardiovasc Res (2002) 1.37

Sepsis and disseminated intravascular coagulation. J Thromb Thrombolysis (2004) 1.36

Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis. Thromb Haemost (2011) 1.35

Activated protein C inhibits local coagulation after intrapulmonary delivery of endotoxin in humans. Am J Respir Crit Care Med (2005) 1.33

Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors. Lancet (2002) 1.32

Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage. Crit Care (2006) 1.32

The effect of electronic medical record-based clinical decision support on HIV care in resource-constrained settings: a systematic review. Int J Med Inform (2012) 1.31

Hospital mortality is associated with ICU admission time. Intensive Care Med (2010) 1.26

The effect of inflammation on coagulation and vice versa. Curr Opin Infect Dis (2011) 1.23

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis. Europace (2011) 1.22

A systematic review on prognostic indicators of acute on chronic liver failure and their predictive value for mortality. Liver Int (2012) 1.22

Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes (2006) 1.22

External validation of Acute Physiology and Chronic Health Evaluation IV in Dutch intensive care units and comparison with Acute Physiology and Chronic Health Evaluation II and Simplified Acute Physiology Score II. J Crit Care (2010) 1.22